Anzeige
Mehr »
Login
Sonntag, 25.10.2020 Börsentäglich über 12.000 News von 649 internationalen Medien
Start der NetCents Krypto-Kreditkarte "powered by VISA" fixiert!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P8AS ISIN: CA4576375022 Ticker-Symbol: MWG 
Frankfurt
23.10.20
16:45 Uhr
2,820 Euro
-0,080
-2,76 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
INMED PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
INMED PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,8202,94024.10.
2,8002,90023.10.

Aktuelle News zur INMED PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
INMED PHARMACEUTICALS Aktie jetzt für 0€ handeln
15.10.InMed Pharmaceuticals Inc. - S-1/A, General form for registration of securities2
09.10.IPO Update: InMed Pharmaceuticals Readies IPO Uplisting4
09.10.Canadian nano-cap biotech InMed Pharmaceuticals sets terms for $10 million Nasdaq uplisting2
08.10.InMed Pharmaceuticals Inc. - S-1/A, General form for registration of securities1
24.09.Inmed Pharmaceuticals Inc (2): Inmed completes subject treatments in INM-755 trial2
24.09.InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects-
22.09.Inmed Pharmaceuticals Inc (2): Inmed files for IntegraSyn patent-
15.09.InMed Pharmaceuticals Inc. - S-1/A, General form for registration of securities4
08.09.InMed Pharmaceuticals Inc. (IMLFF) CEO Eric Adams on Q4 2020 Results - Earnings Call Transcript2
08.09.InMed Pharmaceuticals (IMLFF) Investor Presentation - Slideshow-
08.09.Inmed Pharmaceuticals Inc (2): Inmed spends $7.1M on R&D in fiscal 20201
08.09.InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update2
08.09.InMed Pharmaceuticals reports FY results1
02.09.Inmed Pharmaceuticals Inc (2): Inmed Pharma to issue fiscal 2020 results Sept. 8-
02.09.InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 20201
21.07.InMed Pharmaceuticals Inc. - S-1/A, General form for registration of securities2
07.07.Inmed Pharmaceuticals Inc (2): Inmed to test two strengths of INM-755 in phase 1 trial8
07.07.BRIEF-InMed Pharmaceuticals Announces Dosing Initiation In 2Nd Phase 1 Trial With Inm-7554
07.07.InMed Announces Dosing Initiation in 2nd Phase 1 trial with INM-755-
06.07.InMed Pharmaceuticals Inc. - S-1/A, General form for registration of securities1
Seite:  Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1